NDC 70771-1622 – Emtricitabine and tenofovir disoproxil fumarate

Emtricitabine 167 mg/1; Tenofovir Disoproxil Fumarate 250 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC70771-1622

Product details

Brand name
Emtricitabine and tenofovir disoproxil fumarate
Generic name
Emtricitabine and tenofovir disoproxil fumarate
Labeler
Zydus Lifesciences Limited
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA212689
Marketed since
July 1, 2021
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (3)

Package NDCDescriptionSince
70771-1622-330 TABLET, FILM COATED in 1 BOTTLE (70771-1622-3)Jul 1, 2021
70771-1622-410 BLISTER PACK in 1 CARTON (70771-1622-4) / 10 TABLET, FILM COATED in 1 BLISTER PACK (70771-1622-2)Jul 1, 2021
70771-1622-990 TABLET, FILM COATED in 1 BOTTLE (70771-1622-9)Jul 1, 2021

Other Emtricitabine and tenofovir disoproxil fumarate products